Molecular Partners's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Molecular Partners is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	CHF 2.34M	CHF 11.75M	CHF 172.78M
Gross Profit	-	-	-	-	-
EBIT	-	-	CHF -13.21M	CHF -4.28M	CHF 153.37M
EBITDA	-	-	CHF -12.63M	CHF -3.70M	CHF 154.00M
Net Income Common Stockholders	-	-	CHF -13.32M	CHF -4.52M	CHF 153.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	CHF 186.89M	CHF 249.14M	CHF 267.13M	CHF 285.07M	CHF 296.25M
Total Assets	CHF 198.35M	CHF 262.26M	CHF 281.16M	CHF 299.29M	CHF 311.84M
Total Debt	CHF 3.65M	CHF 4.85M	CHF 5.15M	CHF 5.45M	CHF 5.74M
Net Debt	CHF -183.24M	CHF -244.29M	CHF -261.99M	CHF -279.62M	CHF -290.51M
Total Liabilities	CHF 21.92M	CHF 27.09M	CHF 29.73M	CHF 33.42M	CHF 47.34M
Stockholders Equity	CHF 176.43M	CHF 231.56M	CHF 251.43M	CHF 265.87M	CHF 264.50M
Cash Flow	-
Free Cash Flow	-	-	CHF -18.41M	CHF -12.73M	CHF 163.18M
Operating Cash Flow	-	-	CHF -18.15M	CHF -12.58M	CHF 163.56M
Investing Cash Flow	-	-	CHF -27.42M	CHF -16.04M	CHF -93.56M
Financing Cash Flow	-	-	CHF -923.00K	CHF -279.00K	CHF -70.00K

Currency in CHF

Molecular Partners Earnings and Revenue History

Income Statement >

Molecular Partners Debt to Assets

Balance Sheet >

Molecular Partners Cash Flow

Cash Flow >

Molecular Partners Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing